This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Short bones of upper limb
CD2_BENIGN_BONE_SHORT_UPPER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossium brevium membri superioris
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Short bones of upper limb
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Short bones of upper limb
- Benign neoplasm of bone and articular cartilage
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 566 | 357 | 209 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | 43.74 | 43.28 | 44.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 508
- Matched controls
- 5078
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
+∞
323.0
375
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
93.2
144.1
156
24
2135A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Short bones of upper limb
+∞
89.2
83
*
21304
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium brevium extremitatis superioris
+∞
59.6
56
*
9102
FHL
Trepanation or removal of the local bone process
66.3
56.0
64
11
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
31.3
46.0
61
22
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
6.4
43.6
126
247
NDK10
NOMESCO Finland
Incision or excision of a bone of hand
159.0
29.0
30
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
27.9
25.2
34
13
130
Kela drug reimbursment
Malignant tumour
+∞
23.1
22
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
12.6
22.9
41
35
NDR30
NOMESCO Finland
Complete excision of soft tissue tumour of wrist or hand
114.7
20.7
22
*
NDK99
NOMESCO Finland
Other operation on bone of hand or wrist
76.6
19.8
22
*
WX204
NOMESCO Finland
Axillary plexus blockaced
6.7
19.4
50
81
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.8
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
186.2
17.6
18
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
26.7
17.0
23
9
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.8
16
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
93.2
16.7
18
*
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
8.1
16.4
37
49
115
Kela drug reimbursment
Breast cancer
+∞
15.7
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
143.7
13.5
14
*
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
10.1
12.9
25
26
9104
FHL
Autogenous bone graft
133.1
12.5
13
*
H02AB02
ATC
dexamethasone; systemic
10.9
11.9
22
21
A04AA02
ATC
granisetron; systemic, transdermal
122.7
11.5
12
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
10.8
33
67
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
61.3
10.7
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
112.2
10.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
ND3CG
NOMESCO Finland
Extensive MRI of fingers
30.6
9.4
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
8.9
9.4
19
22
WX203
NOMESCO Finland
Infraclavicular plexus blockade
5.5
9.2
26
49
ND2CG
NOMESCO Finland
Extensive MRI of hand
19.0
9.0
13
7
ZZH40
NOMESCO Finland
Substitute of bone
12.8
8.9
15
12
UJF32
NOMESCO Finland
Coloscopy
2.1
8.9
119
657
SPAT1153
SPAT
Removal of sutures
1.9
8.7
155
953
NDK00
NOMESCO Finland
Excision or incsion of a bone of wrist
50.9
8.7
10
*
HAC20
NOMESCO Finland
Total mastectomy
91.5
8.4
9
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
+∞
8.4
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
M01AH05
ATC
etoricoxib; oral
1.7
8.3
313
2440
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
8.1
240
1734
ZZH20
NOMESCO Finland
Graft of patients own bone
13.3
7.9
13
10
X58
ICD-10 Finland
Exposure to other specified factors
2.2
7.8
79
387
D16.90
ICD-10 Finland
Bone and articular cartilage, unspecified
45.7
7.7
9
*
ND1DG
NOMESCO Finland
Wrist and hand very extensive MRI examination with high intensity magnet
45.7
7.7
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
45.7
7.7
9
*
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.0
7.7
44
156
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.4
7.7
36
112
M25.5
ICD-10 Finland
Pain in joint
1.8
7.6
158
1016
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
7.6
33
97
NDR99
NOMESCO Finland
Other operation for tumour of wrist or hand
81.2
7.4
8
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
7.3
420
3645
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
5.2
7.2
21
42
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.3
7.1
25
61
M67.4
ICD-10 Finland
Ganglion
2.8
7.0
42
156
S62.6
ICD-10 Finland
Fracture of other finger
3.2
6.9
34
111
ND1AD
NOMESCO Finland
Wrist CT examination
11.1
6.8
12
11
L02BA01
ATC
tamoxifen; oral
40.6
6.8
8
*
A02BC02
ATC
pantoprazole; systemic
1.6
6.7
302
2404
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
6.6
19
38
NK6AN
NOMESCO Finland
Total body bone isotope imaging
70.7
6.4
7
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.6
6.3
17
31
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.3
6.3
9
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
ZXA05
NOMESCO Finland
Left side
1.8
6.3
116
714
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.1
91
521
ZXC96
NOMESCO Finland
Robot assisted procedure
12.7
6.1
10
8
SPAT1263
SPAT
Sampling
1.6
6.1
198
1436
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.1
193
1390
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
230
1630
1.69
8.23
4.2
3.8
36.6
36.5
g/l
0.19
208
1523
46
184
2.63
8.04
4.1
1.5
13.6
4.5
ug/l
0.48
38
137
407
3370
1.74
7.92
7.0
5.3
72.9
74.2
u/l
0.44
384
3119
173
1149
1.73
7.77
2.3
2.3
3989.5
6244.4
umol/l
0.31
142
1018
251
1868
1.62
7.14
3.7
3.6
—
—
—
0
0
413
3487
1.68
6.89
4.4
4.0
10.1
10.3
mm/h
0.12
384
3235
134
864
1.72
6.56
1.3
1.3
12.5
10.6
u/ml
0.11
47
362
181
1273
1.62
6.32
2.9
2.0
2.3
2.4
mmol/l
0.31
153
1089
248
1903
1.54
5.84
5.1
5.5
1.2
1.2
mmol/l
0.83
201
1638
133
886
1.66
5.69
1.4
1.3
22.5
28.3
iu/ml
0.36
33
296
225
1701
1.54
5.61
4.4
5.0
1.2
1.2
mmol/l
0.76
201
1519
143
974
1.63
5.60
2.4
2.1
2.8
2.9
mg/l
0.05
121
827
133
898
1.63
5.37
2.2
2.0
—
—
—
0
0
298
2428
1.48
4.99
3.6
4.1
6.4
6.7
mmol/l
1.25
278
2254
298
2444
1.46
4.73
7.5
6.7
3.8
4.1
e9/l
2.53
259
2150
88
558
1.68
4.50
4.0
4.3
32.7
31.4
%
0.50
60
377
85
538
1.68
4.37
5.4
6.1
—
—
—
0
0
508
4716
1.75
4.03
12.8
10.5
22.8
20.4
mg/l
0.74
418
3544
515
4803
1.80
3.98
13.6
11.9
139.8
139.8
mmol/l
0.11
501
4672
85
552
1.64
3.96
2.0
2.2
2.4
2.4
g/l
0.09
79
514
516
4817
1.81
3.94
13.8
12.0
4.0
4.0
mmol/l
0.01
499
4679
22
90
2.50
3.76
1.7
1.2
—
—
—
0
0
91
609
1.59
3.75
1.9
2.3
14.8
14.2
umol/l
0.30
80
559
77
497
1.64
3.68
2.0
2.4
25.0
24.8
%
0.05
61
426
141
1050
1.46
3.52
3.1
2.6
0.4
0.4
e6/l
0.09
108
772
43
238
1.87
3.50
1.6
1.5
—
—
—
0
0
17
64
2.71
3.42
1.2
1.2
—
—
—
0
0
411
3687
1.42
3.38
4.2
3.9
14.8
14.6
pmol/l
1.12
383
3399
250
2073
1.37
3.32
5.5
3.7
11.7
11.1
umol/l
0.15
229
1941
173
1352
1.40
3.29
2.7
2.2
55.2
57.9
u/l
0.56
150
1252
265
2221
1.36
3.28
4.4
4.5
0.0
0.0
estimate
0.50
60
393
250
2077
1.36
3.27
2.9
2.7
102.0
106.2
ug/l
0.15
227
1937
267
2246
1.36
3.20
3.4
3.3
0.0
0.0
estimate
0.80
54
378
476
4406
1.51
3.16
5.0
4.6
6.9
2.1
mu/l
0.45
438
4080
52
319
1.69
3.03
5.3
2.7
230.6
236.1
u/l
0.14
47
296
261
2208
1.34
2.94
3.5
3.2
0.0
0.0
estimate
0.00
58
393
140
1087
1.38
2.71
1.4
1.3
2.7
1.8
u/ml
0.16
38
320
126
967
1.39
2.61
1.4
1.5
—
—
—
0
0
97
712
1.44
2.58
1.8
1.7
1054.1
1177.9
nmol/l
0.88
79
536
206
1714
1.32
2.50
1.9
1.9
100.9
98.1
pmol/l
0.32
105
891
11
39
2.86
2.49
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
89
2.17
2.47
2.0
2.5
0.4
0.4
u/ml
—
10
51
88
642
1.44
2.42
2.7
2.4
0.6
1.0
e6/l
1.28
51
348
144
1143
1.35
2.41
3.7
3.5
0.0
0.0
estimate
0.88
56
392
6
12
5.04
2.40
1.8
1.0
—
—
—
0
0
6
12
5.04
2.40
1.8
1.0
—
—
—
0
0
44
278
1.63
2.34
2.4
2.3
1.2
1.2
mmol/l
0.99
37
230
67
468
1.49
2.30
5.0
5.3
1.0
1.0
mmol/l
0.20
62
431
10
36
2.81
2.21
2.0
1.2
—
—
—
0
0
10
36
2.81
2.21
2.0
1.2
—
—
—
0
0
10
36
2.81
2.21
2.0
1.2
—
—
—
0
0
89
664
1.40
2.17
2.7
1.9
2.4
2.4
mmol/l
0.48
77
580
191
1602
1.29
2.13
2.9
3.2
21.7
59.2
ng/l
0.84
120
982
10
37
2.73
2.11
1.8
1.6
—
—
—
0
0
11
43
2.59
2.10
1.7
1.5
—
—
—
0
0
205
1738
1.28
2.10
3.6
3.3
—
—
—
0
0
18
89
2.06
2.08
1.3
1.1
—
—
—
0
0
112
879
1.34
2.01
1.4
1.6
494.2
35493010.9
pmol/l
1.30
80
741
62
440
1.46
1.99
1.8
2.1
7.3
6.2
umol/l
0.17
50
382
103
801
1.35
1.96
3.0
3.5
151.0
427.5
ng/l
1.53
66
563
5
11
4.58
1.94
2.0
1.0
—
—
—
0
0
5
11
4.58
1.94
2.0
1.0
—
—
—
0
0
15
71
2.14
1.94
2.3
1.8
—
—
—
0
0
26
152
1.74
1.86
1.5
1.6
2.0
0.1
iu/ml
—
5
20
33
207
1.63
1.84
1.4
1.5
—
—
—
0
0
5
12
4.19
1.82
2.4
5.0
—
—
—
0
0
21
116
1.84
1.81
1.3
1.3
—
—
—
0
0
527
5085
1.53
1.80
10.7
8.3
26.4
26.7
u/l
0.19
509
4911
76
576
1.37
1.71
1.9
1.8
—
—
—
0
0
216
1880
1.24
1.70
2.3
2.3
76.8
76.2
nmol/l
0.11
193
1689
78
595
1.36
1.69
2.8
2.6
2.6
3.2
e6/l
0.20
42
301
12
55
2.21
1.68
1.9
1.8
—
—
—
0
0
11
49
2.27
1.64
1.9
1.5
—
—
—
0
0
39
266
1.50
1.56
1.1
1.0
—
—
—
0
0
484
4625
1.32
1.54
4.5
4.3
5.8
5.9
mmol/l
0.27
445
4265
5
125
0.39
1.51
1.8
1.4
—
—
—
0
0
5
125
0.39
1.51
1.6
1.4
—
—
—
0
0
5
125
0.39
1.51
1.6
1.4
—
—
—
0
0
5
125
0.39
1.51
1.6
1.4
—
—
—
0
0
9
38
2.39
1.46
3.8
1.9
—
—
—
0
0
49
357
1.41
1.41
1.8
2.0
74.9
71.7
ml/min/173m2
0.29
23
146
154
1318
1.23
1.39
1.7
2.1
110.7
175.7
u/l
5.22
146
1247
24
151
1.62
1.37
2.5
2.1
105.6
4007.6
u/l
—
5
60
52
386
1.38
1.36
4.2
7.5
11.8
12.0
kpa
0.12
47
375
52
386
1.38
1.36
4.2
7.5
4.9
5.2
kpa
1.27
47
373
14
76
1.86
1.31
2.4
1.8
—
—
—
0
0
6
134
0.44
1.29
1.8
1.5
—
—
—
0
0
52
390
1.37
1.28
4.2
7.5
0.8
1.4
mmol/l
0.84
40
314
547
5358
1.62
1.27
19.8
15.7
136.7
137.5
g/l
0.67
539
5287
14
77
1.84
1.26
1.6
2.0
126.7
134.0
g/l
—
9
55
140
1201
1.22
1.23
4.5
3.5
1.9
1.8
ug/l
0.07
130
1079
10
49
2.06
1.22
2.2
1.1
—
—
—
0
0
51
385
1.36
1.22
1.2
1.2
223.2
128.5
iu/ml
0.61
26
165
5
19
2.65
1.22
1.2
1.3
—
—
—
0
0
11
57
1.95
1.17
1.1
1.1
—
—
—
0
0
10
50
2.02
1.17
2.2
1.1
—
—
—
0
0
10
50
2.02
1.17
2.2
1.1
—
—
—
0
0
8
39
2.07
1.15
1.1
1.2
—
—
—
0
0
0
35
0.00
1.15
0.0
3.8
—
—
—
0
0
5
20
2.51
1.15
2.8
1.3
—
—
—
0
0
5
20
2.51
1.15
2.8
1.3
—
—
—
0
0
5
20
2.51
1.15
2.8
1.3
—
—
—
0
0
5
20
2.51
1.15
2.8
1.3
—
—
—
0
0
54
416
1.33
1.14
2.9
1.9
335.1
365.3
nmol/l
0.60
48
386
69
551
1.29
1.13
2.0
1.9
—
—
—
0
0
51
393
1.33
1.08
1.7
1.8
—
—
—
0
0
169
1494
1.19
1.07
2.8
2.6
28.9
30.4
u/l
0.42
157
1426
23
154
1.51
1.05
1.7
1.7
—
—
—
0
0
34
247
1.40
1.04
1.9
1.6
—
—
—
0
0
9
46
1.97
1.04
1.3
1.6
—
—
—
0
0
11
60
1.85
1.03
1.9
1.7
—
—
—
0
0
9
47
1.93
1.02
2.3
1.1
—
—
—
0
0
9
48
1.89
1.01
2.3
1.1
—
—
—
0
0
9
48
1.89
1.01
2.3
1.1
—
—
—
0
0
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
13
76
1.73
0.99
4.6
1.2
—
1.0
—
0
8
75
617
1.25
0.98
2.0
2.0
—
—
—
0
0
483
4673
1.23
0.97
4.0
3.9
1.3
1.3
mmol/l
0.45
440
4343
78
647
1.24
0.95
1.4
1.7
1.5
1.4
%
0.47
65
576
19
125
1.54
0.95
1.4
1.4
2.7
3.0
g/l
0.66
13
94
13
78
1.68
0.92
4.7
1.3
26.4
40.0
mg/l
0.98
13
71
13
78
1.68
0.92
4.7
1.3
29.1
30.8
mg/l
0.05
13
70
499
4850
1.24
0.92
4.4
4.3
4.7
4.8
mmol/l
0.36
463
4548
25
177
1.43
0.90
1.4
2.2
—
—
—
0
0
36
272
1.35
0.90
1.3
1.4
—
—
—
0
0
22
152
1.47
0.89
1.3
1.2
—
19.4
—
0
9
49
390
1.28
0.86
1.7
1.8
—
—
—
0
0
110
956
1.19
0.85
3.8
3.4
21.2
23.8
%
1.05
53
389
6
31
1.95
0.84
1.3
1.1
—
—
—
0
0
8
45
1.79
0.84
1.1
1.1
—
—
—
0
0
19
129
1.49
0.84
1.4
1.4
3.5
3.9
g/l
0.68
13
91
19
129
1.49
0.84
1.4
1.4
—
—
—
0
0
19
129
1.49
0.84
1.4
1.4
6.6
7.4
g/l
1.85
13
98
118
1034
1.18
0.83
1.6
1.6
0.9
0.8
mg/l
0.07
87
775
8
46
1.75
0.83
1.3
1.7
—
—
—
0
0
40
312
1.30
0.82
2.2
1.8
—
—
—
0
0
6
32
1.88
0.82
1.3
1.1
—
—
—
0
0
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
22
156
1.43
0.80
2.2
1.7
—
—
—
0
0
5
99
0.50
0.78
1.4
1.5
—
—
—
0
0
6
34
1.77
0.76
1.0
1.1
155.2
232.8
mg/l
—
6
29
6
34
1.77
0.76
10.8
1.5
—
—
—
0
0
11
68
1.63
0.72
2.0
2.4
15.3
16.7
%
—
5
36
11
69
1.61
0.69
1.1
1.2
—
—
—
0
0
155
1408
1.14
0.68
3.0
3.2
8.0
7.9
mmol/l
0.12
123
1186
106
941
1.16
0.65
1.5
1.5
22.4
20.8
nmol/l
0.37
88
808
494
4829
1.18
0.64
4.4
4.3
1.5
1.5
mmol/l
0.02
455
4509
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
5
30
1.67
0.61
1.4
1.3
—
—
—
0
0
20
148
1.36
0.60
1.2
1.1
—
8.5
—
0
24
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
455
4428
1.14
0.59
5.5
5.4
38.6
39.4
mmol/mol
1.41
413
4146
44
365
1.22
0.58
3.0
2.7
—
—
—
0
0
11
73
1.52
0.56
1.3
1.2
22.9
15.8
u/l
0.25
11
63
17
125
1.37
0.54
2.2
1.6
—
—
—
0
0
25
196
1.29
0.53
1.9
1.6
—
—
—
0
0
10
66
1.52
0.53
1.2
1.7
—
—
—
0
0
18
135
1.34
0.51
1.1
1.1
—
—
—
0
0
501
4920
1.16
0.50
4.8
4.7
2.8
2.9
mmol/l
0.75
461
4590
109
989
1.13
0.50
3.9
3.5
1.0
1.0
kg/l
0.24
20
119
16
119
1.35
0.48
2.1
2.1
34.4
108.1
ug/min
—
8
71
7
46
1.53
0.48
1.3
1.5
—
—
—
0
0
19
147
1.30
0.45
1.8
1.7
—
—
—
0
0
17
220
0.77
0.45
1.6
1.6
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
24
293
0.81
0.41
2.6
2.4
4.3
4.8
kpa
0.58
24
283
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
342
3310
1.08
0.40
3.2
3.2
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
13
97
1.35
0.39
1.5
1.6
—
—
—
0
0
10
71
1.42
0.39
1.1
1.3
—
—
—
0
0
10
71
1.42
0.39
1.1
1.3
—
—
—
0
0
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
145
1358
1.09
0.38
4.0
4.1
2.9
7.6
mg/mmol
3.08
89
849
5
79
0.63
0.35
1.0
1.1
122.0
121.7
%
—
5
72
17
136
1.26
0.34
1.1
1.1
—
—
—
0
0
114
1064
1.09
0.33
2.1
2.8
944.3
951.1
ng/l
0.01
93
890
10
74
1.36
0.32
1.3
1.6
—
—
—
0
0
62
565
1.11
0.29
2.0
1.7
—
—
—
0
0
7
56
1.25
0.29
2.7
2.8
—
592.2
—
0
6
453
4461
1.08
0.27
11.5
9.1
84.6
84.3
ml/min/173m2
0.11
390
3596
8
64
1.25
0.27
1.4
1.7
—
—
—
0
0
18
214
0.84
0.26
2.7
2.5
0.1
0.1
e6/l
0.92
18
204
8
67
1.20
0.26
1.0
1.0
—
—
—
0
0
15
123
1.23
0.25
1.5
1.4
—
—
—
0
0
20
170
1.18
0.25
1.2
1.3
147.8
224.2
miu/ml
—
10
83
16
133
1.21
0.24
1.0
1.1
—
—
—
0
0
21
243
0.86
0.23
1.1
1.8
2.8
3.2
mg/l
0.14
14
172
5
39
1.28
0.23
1.0
1.4
1.1
1.0
g/l
—
5
39
40
362
1.11
0.22
1.8
2.4
3.5
7.9
ug/l
3.02
32
326
341
3341
1.05
0.22
3.4
2.9
44.8
43.9
u/l
0.08
312
3149
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
81
857
0.94
0.19
1.5
1.5
—
—
—
0
0
446
4511
0.95
0.19
13.7
11.2
40.0
40.6
%
0.71
326
3445
6
53
1.13
0.18
1.0
1.3
—
—
—
0
0
16
138
1.16
0.17
1.3
1.3
—
—
—
0
0
7
62
1.13
0.17
1.4
1.1
—
—
—
0
0
7
63
1.11
0.17
1.0
1.0
1.4
1.4
g/l
—
7
56
26
234
1.12
0.17
1.4
1.4
—
—
—
0
0
72
682
1.06
0.16
2.8
2.5
0.6
0.7
ug/l
1.68
50
411
17
193
0.88
0.16
1.7
1.5
—
—
—
0
0
21
188
1.12
0.15
2.6
1.5
21.4
24.8
u/ml
0.20
21
179
121
1253
0.96
0.14
1.6
1.7
1.5
1.4
mmol/l
0.27
106
1062
33
354
0.93
0.12
2.4
3.3
6.1
5.8
kpa
1.35
33
344
33
352
0.93
0.11
2.6
3.3
2.0
1.8
mmol/l
0.08
28
286
10
87
1.15
0.09
1.3
1.2
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
11.7
—
0
12
401
3981
1.02
0.08
14.3
12.4
13.6
13.5
%
0.38
394
3892
48
499
0.96
0.07
27.6
21.1
1.3
1.2
inr
—
9
76
10
112
0.89
0.07
1.9
2.1
172.0
175.0
%
—
10
104
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
10
89
1.13
0.07
1.2
1.7
—
—
—
0
0
9
105
0.85
0.06
2.2
3.3
—
—
—
0
0
22
208
1.06
0.05
1.2
1.7
—
—
—
0
0
12
130
0.92
0.04
1.8
1.9
6.7
5.9
iu/l
—
6
53
13
140
0.93
0.04
1.8
1.6
—
—
—
0
0
11
119
0.92
0.04
1.4
1.2
—
29.1
—
0
10
45
440
1.02
0.02
5.2
6.0
104.7
104.0
mmol/l
0.54
45
426
12
114
1.05
0.00
1.0
1.3
3.3
3.9
mmol/l
4.05
12
106
12
125
0.96
0.00
2.3
2.4
11.4
11.4
mg/l
0.00
12
118
8
88
0.91
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
1.3
—
0
9
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
69
0.87
0.00
1.7
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
5
51
0.98
0.00
1.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
7
76
0.92
0.00
1.6
1.5
—
—
—
0
0
8
89
0.90
0.00
1.3
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_SHORT_UPPER_EXALLC – Benign neoplasm: Short bones of upper limb
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).